FreeTheAI

BioCardia, Inc.

BCDA · NASDAQ · USD

$1.06

−0.03 −2.75%todayNot financial advice.

BCDA Price chart 6M
Open
1.07
Day range
1.05 - 1.09
52-week range
0.7500 - 1.80
Volume
162.4K
Market cap
16.05M
P/E ratio
—
EPS
-0.76
Dividend yield
0.00%
Beta
0.08

Performance

W

+5.99%

1M

−2.75%

3M

+18.44%

6M

−11.67%

YTD

−16.54%

Y

−19.70%

5Y

−97.65%

All

−100.00%

In the news

  1. Oct 7

    BioCardia Shares CardiAMP HF II Trial Design as FDA Agrees Study May Support Approval

    BioCardia presented its CardiAMP HF II trial design. The FDA agreed the study could support regulatory approval for the heart failure cell therapy.

    Company news

  2. Oct 7

    FDA Agrees BioCardia's CardiAMP HF II Trial May Be Sufficient for Device Approval

    BioCardia, Inc. announced that the FDA agreed its ongoing CardiAMP HF II trial could support approval, potentially shortening its path to market.

    Regulation

Embed on your site

Embed docs

Add a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.

<iframe src="https://stocks.freetheai.org/embed/NASDAQ-BCDA" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="BioCardia, Inc. (BCDA) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-BCDA">BCDA stock price</a> by FreeTheAI Stocks</p>